Antibody Drug Conjugates (ADC) Market

1
Antibody Drug Conjugates (ADC) Market Trends,
Size, Share, Demands, Overview, Growth, Revenue
and Forecast to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Antibody Drug Conjugates (ADC) Market, by Product
Type (Adcetris, Kadcyla, and Other Product
Types), Application (Blood Cancer, Breast Cancer,
Ovary Cancer, Lung Cancer, Skin Cancer, Brain
Tumor, and Other Applications), Technology
(Cleavable Linker and Non-cleavable Linker),
Target Type, End Users and region (North America,
Europe, Asia-Pacific, Middle East and Africa and
South America).
Request For Free Sample Report
https//www.delvens.com/get-free-sample/antibody-d
rug-conjugates-adc-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
Antibody-Drug Conjugates (ADCs) are a class of
targeted cancer therapies that combine the
speciality of monoclonal antibodies (mAbs) with
the potency of cytotoxic drugs. These therapies
are designed to specifically target cancer cells
while minimizing damage to healthy cells, which
can lead to improved treatment efficacy and
reduced side effects compared to traditional
chemotherapy. Several ADCs have been approved for
use in treating various types of cancers,
including breast cancer, lymphoma, and certain
types of leukaemia. However, its important to
note that ADCs may not be suitable for all types
of cancers, and their efficacy and safety depend
on factors such as the target antigen, the
antibody used, the linker technology, and the
cytotoxic payload. Purchase this Report
https//www.delvens.com/checkout/antibody-drug-con
jugates-adc-market
sales_at_delvens.com
www.delvens.com
4
Key Findings
The Antibody Drug Conjugates (ADC) market is
segmented into Product type, application,
technology, target type, end user, and
region Based on product type, the market is
segmented into adcetris, kadcyla, and other
product types. Kadcyla dominated the market in
this segment. Kadcyla specifically targets cancer
cells that overexpress the HER2 protein,
delivering a potent chemotherapy agent directly
to the tumor site. Based on application, the
market is bifurcated into blood cancer, breast
cancer, ovary cancer, lung cancer, skin cancer,
brain tumor, and other applications. The breast
cancer dominated the market in this segment. This
is due to increase in the prevalence of breast
cancer all around the world.
sales_at_delvens.com
www.delvens.com
5
Key Findings
Based on technology, the market is segmented into
cleavable linker and non-cleavable linker. The
cleavable linker ADCs segment dominated the
market in this segment. This is due to their
increased efficacy and safety. The market is
also divided into various regions such as North
America, Europe, Asia-Pacific, South America, and
Middle East and Africa. North America is
estimated to account for the largest market share
during the forecast period. Inquire Before
Buying https//www.delvens.com/Inquire-before-buy
ing/antibody-drug-conjugates-adc-market
sales_at_delvens.com
www.delvens.com
6
Competitive Landscape

• AbbVie Inc.
• ADC Therapeutics SA
• Antikor-M
• AstraZeneca PLC
• Bristol -Myers Squibb
• Catalent Inc.
• F. Hoffmann-La Roche Ltd
• Genentech Inc.
• ImmunoGen Inc.
• Immunomedics Inc.
• Merck Co., Inc.

• Mersana Therapeutics Inc.
• Novartis AG
• Oxford BioTherapeutics Ltd
• Pfizer Inc.
• Seagen Inc.
• Sorrento Therapeutics Inc.
• Sterling Pharma Solutions Limited
• Takeda Pharmaceutical Company Ltd

sales_at_delvens.com
www.delvens.com
7
Recent Developments
In Feb 2022, Adcentrx Therapeutics and AvantGen
entered a three-year, multi-target partnership
for the discovery of antibodies to be developed
into novel ADC therapeutic candidates.  In March
2022, Sanofi and Seagen Inc. entered a
collaboration agreement to design, develop, and
commercialize antibody-drug conjugates (ADCs) for
up to three cancer targets.
sales_at_delvens.com
www.delvens.com
8
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact Us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com